The Two Leading GLP-1 Weight Loss Medications
Semaglutide (Wegovy) and tirzepatide (Zepbound) are the two most widely prescribed injectable weight-loss medications in the United States. Both are highly effective — but they are structurally different drugs with different trial results, side-effect profiles, and costs. Here is what you actually need to know when comparing them with a provider in Boca Raton.
How each medication works
Semaglutide (Wegovy) is a GLP-1 receptor agonist. It mimics the GLP-1 hormone your body produces after eating, which slows gastric emptying, reduces appetite signals, and helps regulate blood sugar. It targets one pathway.
Tirzepatide (Zepbound) is a dual agonist — it activates both GLP-1 and GIP receptors. The additional GIP pathway is believed to contribute to its larger average weight loss in clinical trials. Both medications require weekly self-injection with a prefilled pen, starting at a low dose and escalating gradually under medical supervision.
What the clinical trials show
| Metric (trial data) | Semaglutide (STEP trials) | Tirzepatide (SURMOUNT trials) |
|---|---|---|
| Average weight loss at ~72 weeks | ~15% of body weight | ~20–22% of body weight |
| Patients losing 20%+ | ~32% | ~57% |
| Patients losing 5%+ | ~86% | ~90%+ |
| FDA approval (weight loss) | 2021 (Wegovy) | 2023 (Zepbound) |
| Dosing | Weekly injection, 2.4 mg maintenance | Weekly injection, 15 mg max dose |
These are group averages from registration trials — individual results vary widely based on adherence, lifestyle changes, and how your body responds. Trial results are not a guarantee of your outcome, and your provider should discuss realistic expectations for your situation.
Side effects: how they compare
Both medications share the same class of common side effects, mostly gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are most common during dose escalation and usually improve over time. Both also carry a boxed warning about thyroid C-cell tumors (seen in rodent studies), and both require discussion of gallbladder, pancreatitis, and hypoglycemia risks — especially if combined with other diabetes medications.
The practical difference: tirzepatide's higher efficacy comes with a somewhat higher rate of GI side effects in trials, while semaglutide's more gradual dose schedule is often easier for people sensitive to nausea. This is exactly the kind of trade-off to discuss with a clinician who knows your history.
Cost and insurance coverage
Both medications list for roughly $1,300–$1,400 per month without insurance, and both manufacturers offer savings-card programs for commercially insured patients. Insurance coverage varies by plan — some cover one drug and not the other, some require prior authorization, and some require a trial of one before approving a switch. In Boca Raton, coverage for GLP-1 weight-loss drugs is common but far from universal, so confirming coverage before starting is essential. Ask the pharmacy benefit on your plan and what the out-of-pocket cost would be at maintenance dose.
Which one might be right for you
There is no universal "better" drug — the right choice depends on your medical history, how you tolerate side effects, your insurance coverage, and your goals. Some general observations from the data: people seeking the largest possible average loss may discuss tirzepatide; people with significant nausea sensitivity may find semaglutide's gentler titration easier to tolerate; and your plan's formulary may make the decision for you. A qualified healthcare professional can evaluate your medical history, current medications, and coverage to discuss which option — if either — may be appropriate for you.
What to ask a provider in Boca Raton
- Which of these medications have you prescribed most, and what do your patients typically experience?
- Is my insurance likely to cover either one, and what would my out-of-pocket cost be?
- How do we manage side effects during dose escalation?
- What happens if I stop — how is the transition handled?
- How do you monitor labs and follow up during treatment?
The bottom line
Both semaglutide and tirzepatide are proven, physician-supervised tools — not magic. They work best alongside nutrition guidance, activity, and follow-up, and the decision between them belongs in a conversation with a qualified provider who knows your health history.
Get matched with a provider
Ready to find a provider? Take the 2-minute matching quiz and we'll connect you with Boca Raton providers who offer the type of care you're interested in — no obligation.
More Comparisons
Not sure which comparison you need? Browse all comparisons or take the matching quiz.
Ready to find a provider? Take the 2-minute matching quiz and we'll connect you with Boca Raton providers who offer the type of care you're interested in. Connect with local providers → — no obligation.